Tech Company Financing Transactions

Aprecia Pharmaceuticals Funding Round

On 7/5/2016, Aprecia Pharmaceuticals announced $30 million in funding from Hercules Technology Growth Capital.

Transaction Overview

Announced On
7/5/2016
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Proceeds Purpose
Aprecia has received initial funding of $20 million under the debt financing agreement. The proceeds will be used to purchase additional manufacturing equipment, fund the development and approval of Aprecia's pipeline product candidates and continue to advance its ZipDose technology platform. Under the terms of the agreement, Aprecia has the option to draw up to an additional $10 million tranche upon achievement of a certain performance milestone.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10901 Kenwood Rd.
Blue Ash, OH 45242
USA
Email Address
Overview
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Profile
Aprecia Pharmaceuticals LinkedIn Company Profile
Social Media
Aprecia Pharmaceuticals Company Twitter Account
Company News
Aprecia Pharmaceuticals News
Facebook
Aprecia Pharmaceuticals on Facebook
YouTube
Aprecia Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Thomas Arington
  Thomas Arington LinkedIn Profile  Thomas Arington Twitter Account  Thomas Arington News  Thomas Arington on Facebook
Chief Executive Officer
Christopher Gilmore
  Christopher Gilmore LinkedIn Profile  Christopher Gilmore Twitter Account  Christopher Gilmore News  Christopher Gilmore on Facebook
Chief Financial Officer
Mike Rohlfs
  Mike Rohlfs LinkedIn Profile  Mike Rohlfs Twitter Account  Mike Rohlfs News  Mike Rohlfs on Facebook
Chief Technical Officer
Jaedeok Yoo
  Jaedeok Yoo LinkedIn Profile  Jaedeok Yoo Twitter Account  Jaedeok Yoo News  Jaedeok Yoo on Facebook
Vice President
Don Wetherhold
  Don Wetherhold LinkedIn Profile  Don Wetherhold Twitter Account  Don Wetherhold News  Don Wetherhold on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/4/2016: Paradox Interactive venture capital transaction
Next: 7/5/2016: Catalant venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary